These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 20598117)

  • 1. Myc suppression of Nfkb2 accelerates lymphomagenesis.
    Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
    BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.
    Klapproth K; Sander S; Marinkovic D; Baumann B; Wirth T
    Blood; 2009 Sep; 114(12):2448-58. PubMed ID: 19628709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nfkb 1 is dispensable for Myc-induced lymphomagenesis.
    Keller U; Nilsson JA; Maclean KH; Old JB; Cleveland JL
    Oncogene; 2005 Sep; 24(41):6231-40. PubMed ID: 15940251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma.
    Hunter JE; Butterworth JA; Zhao B; Sellier H; Campbell KJ; Thomas HD; Bacon CM; Cockell SJ; Gewurz BE; Perkins ND
    Oncogene; 2016 Jun; 35(26):3476-84. PubMed ID: 26522720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
    Wang J; Boxer LM
    J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 3' IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype.
    Truffinet V; Pinaud E; Cogné N; Petit B; Guglielmi L; Cogné M; Denizot Y
    J Immunol; 2007 Nov; 179(9):6033-42. PubMed ID: 17947677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis.
    Cardone M; Kandilci A; Carella C; Nilsson JA; Brennan JA; Sirma S; Ozbek U; Boyd K; Cleveland JL; Grosveld GC
    Mol Cell Biol; 2005 Mar; 25(6):2395-405. PubMed ID: 15743832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnitine-acyltransferase system inhibition, cancer cell death, and prevention of myc-induced lymphomagenesis.
    Pacilli A; Calienni M; Margarucci S; D'Apolito M; Petillo O; Rocchi L; Pasquinelli G; Nicolai R; Koverech A; Calvani M; Peluso G; Montanaro L
    J Natl Cancer Inst; 2013 Apr; 105(7):489-98. PubMed ID: 23486551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis.
    Maclean KH; Dorsey FC; Cleveland JL; Kastan MB
    J Clin Invest; 2008 Jan; 118(1):79-88. PubMed ID: 18097482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCL-W has a fundamental role in B cell survival and lymphomagenesis.
    Adams CM; Kim AS; Mitra R; Choi JK; Gong JZ; Eischen CM
    J Clin Invest; 2017 Feb; 127(2):635-650. PubMed ID: 28094768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Id2 is dispensable for myc-induced lymphomagenesis.
    Nilsson JA; Nilsson LM; Keller U; Yokota Y; Boyd K; Cleveland JL
    Cancer Res; 2004 Oct; 64(20):7296-301. PubMed ID: 15492249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.
    Hemann MT; Bric A; Teruya-Feldstein J; Herbst A; Nilsson JA; Cordon-Cardo C; Cleveland JL; Tansey WP; Lowe SW
    Nature; 2005 Aug; 436(7052):807-11. PubMed ID: 16094360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma.
    Jeong SM; Lee A; Lee J; Haigis MC
    J Biol Chem; 2014 Feb; 289(7):4135-44. PubMed ID: 24368766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes.
    Kim KE; Gu C; Thakur S; Vieira E; Lin JC; Rabson AB
    Oncogene; 2000 Mar; 19(10):1334-45. PubMed ID: 10713675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.
    Kelly PN; Grabow S; Delbridge AR; Strasser A; Adams JM
    Blood; 2011 Dec; 118(24):6380-6. PubMed ID: 21998213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis.
    Sander S; Calado DP; Srinivasan L; Köchert K; Zhang B; Rosolowski M; Rodig SJ; Holzmann K; Stilgenbauer S; Siebert R; Bullinger L; Rajewsky K
    Cancer Cell; 2012 Aug; 22(2):167-79. PubMed ID: 22897848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.
    Nilsson JA; Keller UB; Baudino TA; Yang C; Norton S; Old JA; Nilsson LM; Neale G; Kramer DL; Porter CW; Cleveland JL
    Cancer Cell; 2005 May; 7(5):433-44. PubMed ID: 15894264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis.
    Garrison SP; Jeffers JR; Yang C; Nilsson JA; Hall MA; Rehg JE; Yue W; Yu J; Zhang L; Onciu M; Sample JT; Cleveland JL; Zambetti GP
    Mol Cell Biol; 2008 Sep; 28(17):5391-402. PubMed ID: 18573879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis.
    Sabò A; Kress TR; Pelizzola M; de Pretis S; Gorski MM; Tesi A; Morelli MJ; Bora P; Doni M; Verrecchia A; Tonelli C; Fagà G; Bianchi V; Ronchi A; Low D; Müller H; Guccione E; Campaner S; Amati B
    Nature; 2014 Jul; 511(7510):488-492. PubMed ID: 25043028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis.
    Old JB; Kratzat S; Hoellein A; Graf S; Nilsson JA; Nilsson L; Nakayama KI; Peschel C; Cleveland JL; Keller UB
    Mol Cancer Res; 2010 Mar; 8(3):353-62. PubMed ID: 20197382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.